Immunogenicity, Safety and Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA Vaccination in Immunocompromised Adolescents and Young Adults: A systematic Review and Meta-Analyses

Patrick DMC Katoto, Mireille AM Kakubu, Jacques L. Tamuzi, Amanda S. Brand, Adaeze Ayuk, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray
doi: https://doi.org/10.1101/2023.01.20.23284812

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
Posted January 20, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Immunogenicity, Safety and Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA Vaccination in Immunocompromised Adolescents and Young Adults: A systematic Review and Meta-Analyses
Patrick DMC Katoto, Mireille AM Kakubu, Jacques L. Tamuzi, Amanda S. Brand, Adaeze Ayuk, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray
medRxiv 2023.01.20.23284812; doi: https://doi.org/10.1101/2023.01.20.23284812
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area